Want to see SG:A50 full AI Analyst Report?
A50 Stock Chart & Stats
S$0.06
S$0.00(0.00%)
At close: 4:00 PM EST
S$0.06
S$0.00(0.00%)
Day’s Range― - ―
52-Week RangeS$0.05 - S$0.07
Previous CloseN/A
Volume460.80K
Average Volume (3M)2.14M
Market Cap
S$1.40B
Enterprise ValueS$2.45B
Total Cash (Recent Filing)S$103.20M
Total Debt (Recent Filing)S$1.11B
Price to Earnings (P/E)―
Beta0.55
Next Earnings
Aug 31, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding26,443,615,000
10 Day Avg. Volume2,062,170
30 Day Avg. Volume2,143,033
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)2.41
Price to Sales (P/S)2.88
P/FCF Ratio33.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)S$455.90M
Bulls Say, Bears Say
Bulls Say
High Gross MarginA 74.83% gross margin shows the company captures substantial markup on clinical and ancillary services. Such high gross margins provide a durable buffer to cover fixed hospital costs and support reinvestment in facilities and labs, aiding long-term margin recovery if volumes improve.
Specialist Women’s & Children’s FocusConcentration on women’s and children’s health—including obstetrics, gynaecology, fertility and paediatrics—creates a defensible niche. Specialized care drives repeat visits, strong referral networks and less cyclicality, supporting steadier long-term demand and patient retention.
Diversified Clinical Revenue StreamsMultiple revenue channels—hospital inpatient/outpatient fees, specialist professional fees, fertility/IVF services, diagnostics and bundled packages—reduce reliance on any single line. Cross-selling and recurring fertility cycles can steady revenue and improve long-term cash flow resilience.
Bears Say
High LeverageA debt-to-equity of 2.38 and modest equity ratio constrain financial flexibility and raise refinancing and interest-cost risk. High leverage is especially problematic during revenue weakness, limiting the company's ability to invest in capacity or absorb prolonged demand downturns without external funding.
Negative ProfitabilityA -12.05% net margin and negative ROE indicate persistent unprofitability that erodes shareholder equity. Continued losses hamper reinvestment, restrict the ability to fund strategic initiatives from internal cash, and increase dependence on debt or equity raises, raising long-term dilution or solvency risk.
Weak Cash GenerationSeverely negative FCF growth (-636.22%) and low operating-cash-to-net-income (0.22) show poor cash conversion. Weak cash generation raises liquidity and servicing risks for high debt, limits capex and strategic spending, and increases reliance on external financing during recovery periods.
Thomson Medical Group Ltd. News
A50 FAQ
What was Thomson Medical Group Ltd.’s price range in the past 12 months?
Thomson Medical Group Ltd. lowest share price was S$0.04 and its highest was S$0.07 in the past 12 months.
What is Thomson Medical Group Ltd.’s market cap?
Thomson Medical Group Ltd.’s market cap is S$1.40B.
When is Thomson Medical Group Ltd.’s upcoming earnings report date?
Thomson Medical Group Ltd.’s upcoming earnings report date is Aug 31, 2026 which is in 36 days.
How were Thomson Medical Group Ltd.’s earnings last quarter?
Thomson Medical Group Ltd. released its earnings results on Feb 11, 2026. The company reported S$0 earnings per share for the quarter, the consensus estimate of N/A by S$0.
Is Thomson Medical Group Ltd. overvalued?
According to Wall Street analysts Thomson Medical Group Ltd.’s price is currently Overvalued.
Does Thomson Medical Group Ltd. pay dividends?
Thomson Medical Group Ltd. pays a N/A dividend of <S$0.001 which represents an annual dividend yield of N/A. See more information on Thomson Medical Group Ltd. dividends here
What is Thomson Medical Group Ltd.’s EPS estimate?
Thomson Medical Group Ltd.’s EPS estimate is 0.
How many shares outstanding does Thomson Medical Group Ltd. have?
Thomson Medical Group Ltd. has 26,443,615,000 shares outstanding.
What happened to Thomson Medical Group Ltd.’s price movement after its last earnings report?
Thomson Medical Group Ltd. reported an EPS of S$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went up 1.639%.
Which hedge fund is a major shareholder of Thomson Medical Group Ltd.?
Currently, no hedge funds are holding shares in SG:A50
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Thomson Medical Group Ltd.
Operating as an investment holding company, Thomson Medical Group Limited delivers healthcare services specifically tailored for women and children across Singapore, Malaysia, and Vietnam. Its core assets include the Thomson Medical Centre, alongside an extensive network of affiliated medical clinics and healthcare facilities. The group's service portfolio encompasses immediate care solutions, covering basic resuscitation, ECG, vaccinations, intravenous fluid and antibiotic treatments, minor surgeries and procedures, wound management, and essential diagnostic imaging like X-rays and laboratory tests. Additionally, it provides comprehensive health screening, aesthetic and dermatological services, pain and rehabilitation management, and traditional herbal tea offerings. Furthermore, Thomson Medical Group specializes in a broad spectrum of medical areas. These include women's and children's health, fertility and family planning, ophthalmology, general surgery, urology, preventive health, healthy aging, advanced diagnostic imaging, breast care, cardiology, respiratory and critical care, endocrinology, dermatology, day surgery, general surgical care, counselling, therapy, Traditional Chinese Medicine (TCM), and specialized care for bone, joint, gynecological oncology, dental, and spine conditions. The company's diverse range of products and services are marketed under well-known brands such as Thomson Women's Clinic, Thomson Fertility Centre, Thomson Paediatric Clinic, Thomson Specialists, Thomson Chinese Medicine, Thomson Surgical Centre, Thomson Dental Centre, Thomson Hospital Kota Damansara, TMC Fertility, TMC Care Pharmacy, FV Hospital, and FV Saigon Clinic. Established in 1979, Thomson Medical Group Limited is headquartered in Singapore.
Technical Analysis
Cordlife Group
―
Raffles Medical Group
―
Asiamedic Limited
―
OUE Lippo Healthcare Limited
―
Bangkok Dusit Medical Services Public Co Ltd Shs UnSp Singapore Depositary Receipt Repr 2/1 Sh
―